Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;184(4):876-884.
doi: 10.1002/ajmg.c.31848. Epub 2020 Oct 20.

The odyssey of complex neurogenetic disorders: From undetermined to positive

Affiliations

The odyssey of complex neurogenetic disorders: From undetermined to positive

Valeria Salinas et al. Am J Med Genet C Semin Med Genet. 2020 Dec.

Abstract

The genetic and phenotypic heterogeneity of neurogenetic diseases forces patients and their families into a "diagnostic odyssey." An increase in the variability of genetic disorders and the corresponding gene-disease associations suggest the need to periodically re-evaluate the significance of variants of undetermined pathogenicity. Here, we report the diagnostic and clinical utility of Targeted Gene Panel Sequencing (TGPS) and Whole Exome Sequencing (WES) in 341 patients with suspected neurogenetic disorders from centers in Buenos Aires and Cincinnati over the last 4 years, focusing on the usefulness of reinterpreting variants previously classified as of uncertain significance. After a mean of ±2years (IC 95:0.73-3.27), approximately 30% of the variants of uncertain significance were reclassified as pathogenic. The use of next generation sequencing methods has facilitated the identification of both germline and mosaic pathogenic variants, expanding the diagnostic yield. These results demonstrate the high clinical impact of periodic reanalysis of undetermined variants in clinical neurology.

Keywords: diagnostic odyssey; mosaicism; targeted gene panel sequencing; variants of unknown significance; whole exome sequencing.

PubMed Disclaimer

References

REFERENCES

    1. Carmichael, N., Tsipis, J., Windmueller, G., Mandel, L., & Estrella, E. (2015). "is it going to hurt?": The impact of the diagnostic odyssey on children and their families. Journal of Genetic Counseling, 24(2), 325-335. https://doi.org/10.1007/s10897-014-9773-9
    1. Chisholm, C., Daoud, H., Ghani, M., Mettler, G., McGowan-Jordan, J., Sinclair-Bourque, L., … Jarinova, O. (2018). Reinterpretation of sequence variants: One diagnostic laboratory's experience, and the need for standard guidelines. Genetics in Medicine, 20(3), 365-368. https://doi.org/10.1038/gim.2017.191
    1. Cohen, L., Manín, A., Medina, N., Rodríguez-Quiroga, S., González-Morón, D., Rosales, J., … Vega, P. (2020). Argentinian clinical genomics in a leukodystrophies and genetic leukoencephalopathies cohort: Diagnostic yield in our first 9 years. Annals of Human Genetics, 84(1), 11-28. https://doi.org/10.1111/ahg.12345
    1. Córdoba, M., Rodriguez-Quiroga, S. A., Vega, P. A., Salinas, V., Perez-Maturo, J., Amartino, H., … Kauffman, M. A. (2018). Whole exome sequencing in neurogenetic odysseys: An effective, cost- and time-saving diagnostic approach. PLoS One, 13(2), e0191228. https://doi.org/10.1371/journal.pone.0191228
    1. de Lange, I. M., Koudijs, M. J., van 't Slot, R., Gunning, B., Sonsma, A., van Gemert, L., … Koeleman, B. (2018). Mosaicism of de novo pathogenic SCN1A variants in epilepsy is a frequent phenomenon that correlates with variable phenotypes. Epilepsia, 59(3), 690-703. https://doi.org/10.1111/epi.14021

Publication types

LinkOut - more resources